EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Transformative Role of Nanotechnology in the Management of Diabetes Mellitus: Insights from Current Research

Natalia G Vallianou iD, Maria Dalamaga iD, Argyro Pavlou, Eleni Rebelos, Nikolaos Nektarios Karamanolis, Eleftheria Papachristoforou iD, Evangelos Mavrothalassitis, Ioanna Eleftheriadou iD, Nikolaos Tentolouris iD, Dimitris Kounatidis iD

Biomolecules · 2025

DOI: 10.3390/biom15050653 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Natalia G Vallianou und 9 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Internal Medicine, Sismanogleio General Hospital, 15126 Athens, Greece. Hauptthemen laut MEDLINE: Diabetes Mellitus, Nanomedicine, Nanotechnology, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanotechnology refers to the science that modulates molecules to the nanoscale dimension. Nanomedicine, i.e., the utilization of nanotechnology for diagnosing and treating several disorders, is a subject of ongoing research. The concept behind nanomedicine in diabetes mellitus (DM) treatment stems from the need to ameliorate absorption and distribution of antidiabetic therapies in order to overcome barriers, namely the pH throughout the gastrointestinal tract, the gut microbiota, the temperature/heat and the difficulties in the incorporation of drugs into the cells. Thus, the scope of nanomedicine is particularly challenging and demanding, considering the fact that the human body is a perpetually changing entity in order to achieve homeostasis. In this review, we will delve into various nanoparticles that are being studied in terms of antidiabetic treatment, their pros and cons and the expanding knowledge in this field. Despite the fact that nanomedicine seems to be very promising, there are still many gaps in our understanding of how the human body addresses its utilization. Moreover, its high costs, along with an as-yet unclear safety profile, remain a significant barrier to widespread adoption. In this review, we will describe both phytochemicals and chemical compounds that nanomedicine seeks to exploit in order to pave the way for a more efficacious and comprehensive management of diabetes mellitus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusNanomedicineNanotechnologyHypoglycemic AgentsHumansAnimalsNanoparticlesPhytochemicals

Stichwörter der Autor:innen

diabetes mellitusdiabetic woundsinsulin delivery systemsnanomedicinenanotechnologyphytochemicals

Substanzen

Hypoglycemic AgentsPhytochemicals

Autor:innen und Institutionen

  • First Department of Internal Medicine, Sismanogleio General Hospital, 15126 Athens, Greece.
  • Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Diabetes Center, First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece.
  • Second Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital, 11527 Athens, Greece.

ORCID-Profile: Natalia G Vallianou, Maria Dalamaga, Eleftheria Papachristoforou, Ioanna Eleftheriadou, Nikolaos Tentolouris, Dimitris Kounatidis

Zitieren

APA

Vallianou, N. G., Dalamaga, M., Pavlou, A., Rebelos, E., Karamanolis, N. N., Papachristoforou, E., Mavrothalassitis, E., Eleftheriadou, I., Tentolouris, N., & Kounatidis, D. (2025). The Transformative Role of Nanotechnology in the Management of Diabetes Mellitus: Insights from Current Research. Biomolecules. https://doi.org/10.3390/biom15050653

Vancouver

Vallianou NG, Dalamaga M, Pavlou A, Rebelos E, Karamanolis NN, Papachristoforou E, et al. The Transformative Role of Nanotechnology in the Management of Diabetes Mellitus: Insights from Current Research. Biomolecules. 2025. doi:10.3390/biom15050653

BibTeX
@article{Vallianou2025,
  author = {Vallianou, Natalia G and Dalamaga, Maria and Pavlou, Argyro and Rebelos, Eleni and Karamanolis, Nikolaos Nektarios and Papachristoforou, Eleftheria and Mavrothalassitis, Evangelos and Eleftheriadou, Ioanna and Tentolouris, Nikolaos and Kounatidis, Dimitris},
  title = {The Transformative Role of Nanotechnology in the Management of Diabetes Mellitus: Insights from Current Research},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15050653}
}
Kostenlos starten →